key: cord-0851350-n8z01hnx authors: Malek, Alexandre E.; Dagher, Hiba; Hachem, Ray; Chaftari, Anne M.; Raad, Issam I. title: Is a single dose of mRNA vaccine sufficient for COVID‐19 survivors? date: 2021-03-14 journal: J Med Virol DOI: 10.1002/jmv.26915 sha: 59ca829daed35e203e77b62c93e399f2cbd63c60 doc_id: 851350 cord_uid: n8z01hnx Amidst the evolving COVID-19 pandemic and its precarious conditions that have impacted the worldwide community, the need to achieve a herd immunity through immunization has become the only resort to control this horrendous pandemic. This article is protected by copyright. All rights reserved. Dear Editor, Amidst the evolving COVID-19 pandemic and its precarious conditions that have impacted the worldwide community, the need to achieve herd immunity through immunization has become the only Hence, assessing the clinical benefits of mRNA vaccines in patients who recovered from COVID-19 is of utmost importance given COVID-19 Map -Johns Hopkins Coronavirus Resource Center FDA-authorized COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system. medRxiv Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients Assessment of the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection in an intense reexposure setting SARS-CoV-2 reinfection in a cohort of 43,000 antibody-positive individuals followed for up to 35 weeks. medRxiv Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines|CDC